US FDA requires ‘boxed warning’ on CAR-T cancer therapies

A U.S. health regulator said Monday that companies will be required to add a strong warning to prescribing information for cancer drugs known as CAR-T by Gilead Sciences, Johnson & Johnson, Novartis and others.

Share This Post:

POPULAR POSTS
FOLLOW US
Like Us On Facebook
Follow Us On Twitter
Subscribe To Our Channel
TikTok
LIVE STREAM